BIOVAXYS TECHNOLOGY CORP (BVAXF)
BVAXF moved a median of +0.20% 30 minutes after news, and +4.31% by the close. How BVAXF actually reacts to news — the realized, point-in-time move the market made, measured across 138 labeled events over the last three years with zero look-ahead.
BVAXF’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 40% | 126 |
| 30-min | +0.20% | 51% | 132 |
| 60-min | +0.73% | 56% | 133 |
| to close | +4.31% | 64% | 134 |
| Middle 50% of BVAXF reactions | 0.00% to +4.57% |
|---|---|
| Median reaction (30-min) | +0.20% |
| Measured reactions | 138 |
Half of all BIOVAXYS TECHNOLOGY CORP news events land between +0.00% and +4.57% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when BVAXF moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BVAXF's baseline. Nothing else.
Recent BVAXF events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M | Press release | Canada Newswire | +7.14% | +11.04% | |
| BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES | Press release | Canada Newswire | -2.99% | -1.54% | |
| BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES | Press release | Canada Newswire | +0.00% | -3.65% | |
| BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES AND GRANT OF STOCK OPTIONS | Press release | Canada Newswire | +2.15% | +12.51% | |
| BIOVAXYS APPOINTS FORMER SANOFI VACCINES EXECUTIVE TO BOARD OF DIRECTORS | Press release | PR Newswire | — | — | |
| BIOVAXYS ANNOUNCES SHARE CONSOLIDATION | Press release | Canada Newswire | — | — | |
| BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE | Press release | Canada Newswire | +0.00% | -5.00% | |
| BIOVAXYS ENGAGES ENCLAVE CAPITAL LLC TO ACT AS AN AGENT IN BROKERED PRIVATE PLACEMENT OFFERING | Press release | Canada Newswire | +1.95% | +2.34% | |
| BIOVAXYS ANNOUNCES AMENDED LIFE OFFERING | Press release | Canada Newswire | +0.00% | +0.73% | |
| BioVaxys Issues Corporate Update | Press release | Canada Newswire | -7.02% | -1.67% | |
| BIOVAXYS ANNOUNCES CONSOLIDATION AND CONCURRENT BROKERED PRIVATE PLACEMENT OFFERING FOR GROSS PROCEEDS OF UP TO $3,000,000 | Press release | Canada Newswire | +17.65% | +18.82% | |
| BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA") | Press release | Canada Newswire | +17.65% | +18.82% | |
| BioVaxys and Sona Nanotech Enter Research Collaboration | Press release | Canada Newswire | +0.00% | +26.49% | |
| BioVaxys and SpayVac-for-Wildlife Expand License Agreement Into Commercial Aquaculture | Press release | Canada Newswire | +4.04% | +5.80% | |
| BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update | Press release | PR Newswire | +0.13% | -5.14% | |
| BioVaxys Technology Corp. Granted Management Cease Trade Order | Press release | Canada Newswire | -9.71% | -10.55% | |
| BioVaxys Announces Application for Management Cease Trade Order | Press release | Canada Newswire | -6.37% | +5.12% | |
| BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030* | Press release | Canada Newswire | +7.06% | +2.91% | |
| BioVaxys Technology Corp. to Present at the Emerging Growth Conference on Thursday January 16, 2025 | Press release | Canada Newswire | +0.00% | +11.14% | |
| BioVaxys Secures GMP-Grade Lipid Supply for Production of DPX-Based Vaccines in Advance of Preclinical and Clinical Program Ramp-Up | Press release | PR Newswire | +1.51% | +23.26% | |
| BioVaxys Shares New Data on its DPX™ Immune Educating Platform at Personalized Cancer Vaccine Summit | Press release | Canada Newswire | +0.00% | +4.31% | |
| BIOVAXYS PARTNER SPAYVAC FOR WILDLIFE, INC., SCALES-UP VACCINE PRODUCTION CAPACITY | Press release | PR Newswire | +2.88% | +3.70% | |
| BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium | Press release | Canada Newswire | -7.50% | -9.67% | |
| BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems | Press release | PR Newswire | +4.41% | +6.39% | |
| BioVaxys to Present at the Emerging Growth Conference on October 30th, 2024 | Press release | Canada Newswire | +0.00% | +1.85% | |
| BioVaxys Announces Marketing Program | Press release | PR Newswire | -3.56% | -4.44% | |
| BioVaxys Engages Dr. Rajkannan Rajagopalan as Vaccine Formulations Advisor | Press release | PR Newswire | +0.30% | +12.88% | |
| BIOVAXYS ANNOUNCES UPSIZING OF PRIVATE PLACEMENT | Press release | Canada Newswire | +0.00% | +0.00% | |
| BioVaxys Technology Corp. to Present at the Life Sciences Investor Forum September 19th 2024 | Press release | GlobeNewswire | — | +9.49% | |
| BioVaxys to Present at the Life Sciences Investor Forum on September 19th | Press release | PR Newswire | +4.72% | +4.72% | |
| BIOVAXYS ANNOUNCES CLOSING OF THIRD TRANCHE OF PRIVATE PLACEMENT | Press release | Canada Newswire | +4.72% | +4.72% | |
| BioVaxys to Present New Data on its DPX Immune Educating Platform at Personalized Cancer Vaccine Summit | Press release | Canada Newswire | +0.00% | +4.22% | |
| BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases | Press release | Canada Newswire | +0.00% | +9.52% | |
| SPAYVAC FOR WILDLIFE, INC. ANNOUNCES COMPLETION OF SPAYVAC RESEARCH AND PRODUCTION FACILITY IN MADISON, WISCONSIN | Press release | Canada Newswire | +0.00% | -1.00% | |
| Biovaxys Signs Binding Letter of Intent to Develop DPX™-Based Vaccines for Life Threatening Food Allergies | Press release | Canada Newswire | +0.00% | -9.31% | |
| BIOVAXYS ANNOUNCES ISSUANCE OF DPX RELATED PATENT FROM THE U.S. PATENT AND TRADEMARK OFFICE | Press release | Canada Newswire | +24.09% | +21.41% | |
| BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT AND DEBT SETTLEMENT | Press release | Canada Newswire | +12.23% | +18.76% | |
| Brittany Davison, CPA, CA, Joins BioVaxys as Business Advisor | Press release | Canada Newswire | +0.00% | +27.84% | |
| BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF TRIAL TO TEST IMMUNOCONTRACEPTION IN ASIAN ELEPHANTS | Press release | Canada Newswire | +17.38% | -9.71% | |
| BioVaxys Technology Corp. Announces Revocation of Cease Trade Order | Press release | Canada Newswire | +7.18% | +35.77% | |
| Form D BioVaxys Technology Corp | SEC filing · Form D | SEC EDGAR | +7.18% | +35.77% | |
| BioVaxys Technology Corp. Announces Failure to File Cease Trade Order | Press release | Canada Newswire | — | +0.00% | |
| BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update | Press release | Canada Newswire | +0.00% | +7.95% | |
| Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 | Press release | Canada Newswire | — | -7.38% | |
| BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER | Press release | Canada Newswire | +0.00% | +4.01% | |
| BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update | Press release | Canada Newswire | -6.43% | +9.22% | |
| BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY | Press release | Canada Newswire | +0.00% | +0.00% | |
| BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update | Press release | Canada Newswire | +3.51% | +0.00% | |
| BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE | Press release | Canada Newswire | +0.00% | -1.72% | |
| BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT | Press release | Canada Newswire | +0.00% | -9.93% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BVAXF section they belong to.
Where else BVAXF is measured.
BVAXF earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is BIOVAXYS TECHNOLOGY CORP's median reaction calculated?
Every labeled BVAXF news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 138 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 51% of BVAXF's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BVAXF's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.